Sources | Names Used |
---|---|
GDSC1000, FIMM | Bexarotene |
CTRPv2 | bexarotene |
PharmacoGx | Bexarotene |
Database | Identifier |
---|---|
Smiles: | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
Inchikey: | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
Pubchem: | 82146 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MSC | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | SLC2A5 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
mRNA | ATP12A | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | MS4A6E | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | UBE2D3 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | IL21 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
mRNA | NLRP3 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-09 |
mRNA | TBC1D30 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-09 |
mRNA | ZYX | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | RNH1 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |